Gujarat Fluorochemicals (FLUOROCHEM)₹4,575−0.08%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Gujarat Fluorochemicals reported sales of ₹1,588 Cr, up 24.1% from Jun 2025, and net profit of ₹219 Cr, up 20.4% year on year. For the year to Mar 2026, sales were ₹4,996 Cr and net profit ₹555 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 946 | 992 | 1,133 | 1,175 | 1,188 | 1,148 | 1,224 | 1,280 | 1,210 | 1,135 | 1,369 | 1,588 |
| Expenses | 784 | 787 | 897 | 915 | 894 | 855 | 920 | 937 | 846 | 862 | 1,063 | 1,163 |
| Operating Profit | 164 | 207 | 239 | 263 | 296 | 295 | 307 | 345 | 365 | 276 | 308 | 427 |
| OPM % | 17.0% | 21.0% | 21.1% | 22.0% | 25.1% | 26.0% | 25.0% | 27.1% | 30.1% | 24.0% | 22.0% | 27.1% |
| Other Income | 13.04 | 13.04 | 18.05 | 9.03 | 9.04 | 14.05 | 26.11 | 23.08 | 6.02 | −10.04 | 3.01 | 12.04 |
| Interest | 33.92 | 36.91 | 33.90 | 36.95 | 41.91 | 41.92 | 25.93 | 29.93 | 32.92 | 32.92 | 41.93 | 25.93 |
| Depreciation | 68.04 | 72.13 | 81.10 | 85.17 | 90.15 | 91.16 | 89.14 | 90.15 | 91.17 | 89.17 | 97.18 | 102 |
| Profit before tax | 74.86 | 110 | 141 | 149 | 172 | 175 | 217 | 247 | 246 | 143 | 171 | 310 |
| Tax % | 29.1% | 27.1% | 28.1% | 28.1% | 30.1% | 28.0% | 12.1% | 26.0% | 27.1% | 29.0% | 42.1% | 29.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −10.99 | −1.99 | 0.00 |
| Net Profit | 52.97 | 79.90 | 101 | 108 | 121 | 126 | 191 | 182 | 179 | 102 | 99.86 | 219 |
| EPS (Rs) | 4.80 | 7.25 | 9.15 | 9.80 | 10.99 | 11.43 | 17.33 | 16.52 | 16.23 | 9.25 | 9.35 | 20.03 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,850 | 2,729 | 2,603 | 2,648 | 3,952 | 5,682 | 4,279 | 4,735 | 4,996 | 5,302 |
| Expenses | 3,108 | 1,942 | 2,170 | 2,056 | 2,788 | 3,722 | 3,372 | 3,640 | 3,709 | 3,934 |
| Operating Profit | 746 | 790 | 440 | 600 | 1,171 | 1,969 | 918 | 1,103 | 1,293 | 1,375 |
| OPM % | 19.0% | 29.0% | 17.1% | 23.1% | 30.0% | 35.0% | 21.1% | 23.0% | 26.0% | 25.9% |
| Other Income | 112 | 78.23 | 191 | 200 | 161 | 172 | 100 | 115 | 22.07 | 11.03 |
| Interest | 278 | 55.85 | 105 | 113 | 77.89 | 117 | 133 | 147 | 138 | 134 |
| Depreciation | 299 | 164 | 192 | 202 | 205 | 236 | 286 | 356 | 368 | 380 |
| Profit before tax | 279 | 644 | 332 | 481 | 1,043 | 1,783 | 594 | 712 | 806 | 869 |
| Tax % | 14.1% | −93.0% | 43.0% | 146.1% | 26.1% | 26.1% | 27.1% | 23.1% | 31.1% | — |
| Exceptional items | 5.99 | −1.99 | −13.99 | −1.99 | 15.98 | 1.99 | −4.99 | 0.00 | −13.98 | −12.98 |
| Net Profit | 240 | 1,245 | 189 | −222 | 775 | 1,321 | 435 | 546 | 555 | 599 |
| EPS (Rs) | — | — | 17.81 | −19.82 | 71.35 | 120.53 | 39.43 | 49.54 | 50.91 | 54.86 |
| Dividend payout % | 15.0% | 0.0% | 0.0% | 0.0% | 6.0% | 3.0% | 8.0% | 6.0% | 6.0% | — |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.04 | 11.05 | 11.05 | 11.05 | 11.05 | 11.04 | 11.04 | 11.05 | 11.05 |
| Reserves | 4,762 | 3,507 | 3,712 | 3,490 | 4,254 | 5,521 | 5,935 | 7,261 | 7,873 |
| Borrowings | 1,998 | 968 | 1,718 | 1,591 | 1,556 | 1,515 | 2,095 | 2,081 | 2,292 |
| Other Liabilities | 3,000 | 443 | 637 | 889 | 1,072 | 1,341 | 1,207 | 1,276 | 1,735 |
| Total Liabilities | 9,771 | 4,929 | 6,077 | 5,981 | 6,892 | 8,388 | 9,248 | 10,629 | 11,911 |
| Fixed Assets | 3,814 | 2,307 | 2,416 | 2,369 | 2,517 | 3,113 | 4,267 | 4,291 | 4,838 |
| CWIP | 727 | 230 | 319 | 402 | 683 | 1,163 | 1,131 | 1,575 | 1,897 |
| Investments | 526 | 343 | 260 | 88.23 | 20.08 | 1.01 | 1.01 | 290 | 279 |
| Other Assets | 4,704 | 2,049 | 3,083 | 3,122 | 3,674 | 4,112 | 3,849 | 4,473 | 4,896 |
| Inventories | 1,311 | 640 | 812 | 862 | 944 | 1,483 | 1,567 | 1,815 | 1,928 |
| Trade receivables | 1,951 | 576 | 567 | 670 | 780 | 1,110 | 848 | 1,200 | 1,285 |
| Cash & equivalents | 195 | 40.90 | 16.97 | 21.96 | 153 | 161 | 198 | 222 | 349 |
| Total Assets | 9,771 | 4,929 | 6,077 | 5,981 | 6,892 | 8,388 | 9,248 | 10,629 | 11,911 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 949 | 779 | 544 | 614 | 738 | 736 | 624 | 543 | 958 |
| Cash from investing activity | 591 | −429 | −1,157 | −374 | −586 | −478 | −969 | −1,125 | −1,173 |
| Cash from financing activity | −1,672 | 110 | 624 | −249 | −144 | −265 | 349 | 601 | 368 |
| Net cash flow | −127 | 465 | 17.06 | −5.02 | 14.04 | −2.01 | 7.02 | 24.09 | 161 |
| Capex | 1,020 | 522 | 1,200 | 275 | 676 | 733 | 973 | 884 | 1,256 |
| Free cash flow | −64.25 | 277 | −652 | 344 | 92.25 | 12.04 | −331 | −336 | −292 |
| CFO / OP % | 157.1% | 101.1% | 136.1% | 80.1% | 83.0% | 62.0% | 90.0% | 67.1% | 94.1% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 183 | 76 | 78 | 91 | 71 | 70 | 71 | 91 | 93 |
| Inventory days | 736 | 351 | 390 | 404 | 314 | 375 | 435 | 487 | 430 |
| Days payable | 470 | 126 | 175 | 201 | 169 | 173 | 143 | 161 | 122 |
| Cash conversion cycle | 450 | 302 | 294 | 295 | 217 | 273 | 364 | 419 | 402 |
| Working capital days | 67 | 22 | 0 | 6 | 33 | 62 | 60 | 97 | 109 |
| ROCE % | — | 11.1% | 9.0% | 11.1% | 20.1% | 30.0% | 10.0% | 10.1% | 10.1% |
For the Jun 2026 quarter, Gujarat Fluorochemicals reported sales of ₹1,588 Cr, up 24.1% year on year and net profit of ₹219 Cr, up 20.4% year on year. The operating margin was 27.1%.
Gujarat Fluorochemicals' sales for the year to Mar 2026 were ₹4,996 Cr; over the last twelve months they were ₹5,302 Cr.
Net profit for the year to Mar 2026 was ₹555 Cr, and ₹599 Cr over the last twelve months. Earnings per share over the same trailing period were ₹54.86.
Gujarat Fluorochemicals reported borrowings of ₹2,292 Cr at Mar 2026, against cash and equivalents of ₹349 Cr.
Cash from operations was ₹958 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹292 Cr.